Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers Remain
The Oncologist · 02.11.2023 · 28 (11) · e1092-e1098
DOI: 10.1093/oncolo/oyad141 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 01.06.2023. Verfasst von Yuval Shalev Many und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Terminal Care, Neoplasms, Hospices. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cancer remains a leading cause of mortality worldwide. While the main focus of palliative care (PC) is quality of life, the elements that comprise the quality of death are often overlooked. Dying at home, with home-hospice-care (HHC) support, rather than in-hospital, may increase patient satisfaction and decrease the use of invasive measures. We examined clinical and demographic characteristics associated with out-of-hospital death among patients with cancer, which serves as a proxy measure for HHC deaths.
Methods
Using death certification data from the Israel Central Bureau of Statistics, we analyzed 209,158 cancer deaths between 1998 and 2018 in Israel including demographic information, cause of death, and place of death (POD). A multiple logistic regression model was constructed to identify factors associated with out-of-hospital cancer deaths.
Results
Between 1998 and 2018, 69.1% of cancer deaths occurred in-hospital, and 30.8% out-of-hospital. Out-of-hospital deaths increased by 1% annually during the study period. Older patients and those dying of solid malignancies were more likely to die out-of-hospital (OR = 2.65, OR = 1.93, respectively). Likelihood of dying out-of-hospital varied with area of residency; patients living in the Southern district were more likely than those in the Jerusalem district to die out-of-hospital (OR = 2.37).
Conclusion
The proportion of cancer deaths occurring out-of-hospital increased during the study period. We identified clinical and demographic factors associated with POD. Differences between geographical areas probably stem from disparity in the distribution of PC services and highlight the need for increasing access to primary EOL care. However, differences in age and tumor type probably reflect cultural changes and suggest focusing on educating patients, families, and physicians on the benefits of PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Pain and Palliative Care Unit, Department of Family Medicine, Ben Gurion University, Beer Sheva, Israel.
- The Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Israel National Cancer Registry, Israel Ministry of Health, Ramat Gan, Israel.
ORCID-Profile: Yuval Shalev Many
Zitieren
APA
Shalev Many, Y., Shvartzman, P., Wolf, I., & Silverman, B. G. (2023). Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers Remain. The Oncologist, 28(11), e1092-e1098. https://doi.org/10.1093/oncolo/oyad141
Vancouver
Shalev Many Y, Shvartzman P, Wolf I, Silverman BG. Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers Remain. The Oncologist. 2023;28(11):e1092-e1098. doi:10.1093/oncolo/oyad141
BibTeX
@article{ShalevMany2023,
author = {Shalev Many, Yuval and Shvartzman, Pesach and Wolf, Ido and Silverman, Barbara G},
title = {Place of Death for Israeli Cancer Patients Over a 20-Year Period: Reducing Hospital Deaths, but Barriers Remain},
journal = {The Oncologist},
year = {2023},
volume = {28},
number = {11},
pages = {e1092--e1098},
doi = {10.1093/oncolo/oyad141}
}
EUVIMED